Tech Network Grenada: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech Network Grenada.

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

April 2026

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30

Press releases published on April 17, 2026

2 hours ago

Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026

GlobeNewswire

2 hours ago

Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial

GlobeNewswire

2 hours ago

PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma

GlobeNewswire

2 hours ago

Asgard Therapeutics to present preclinical data on lead asset AT-108, a personalized, off-the-shelf gene therapy, at AACR Annual Meeting 2026

GlobeNewswire

2 hours ago

New data demonstrates the unique scalability of Evaxion’s AI-Immunology™ platform in glioblastoma

GlobeNewswire

2 hours ago

Pheast Therapeutics Reports Initial Phase 1a Data Showing Early Clinical Activity and Target Engagement for PHST001 at AACR 2026

GlobeNewswire

2 hours ago

Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform

GlobeNewswire

2 hours ago

Biolojic Design Presents New Preclinical Data for BD200, a First-in-Class Multibody-Drug Conjugate Targeting Trop-2 and Nectin-4 at the American Association of Cancer Research Annual Meeting

GlobeNewswire

$MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer$

2 hours ago

MiNK Therapeutics Reports Phase II Data on Immune Reprogramming and Durable Survival in PD-1 Refractory Gastroesophageal Cancer

GlobeNewswire

4 hours ago

Verum Messenger Introduces Major Platform Update Expanding Privacy, Connectivity, and Digital Ecosystem

GlobeNewswire

4 hours ago

Studio 6 Grows Extended Stay Footprint with 35+ New Locations in 2026

GlobeNewswire

4 hours ago

Rebalancing Agents Hympavzi (Pfizer), Qfitlia (Sanofi), Alhemo (Novo Nordisk) Gain Ground in Hemophilia as Physicians Navigate Access Barriers and Expanding Treatment Complexity

GlobeNewswire

4 hours ago

Kaltura to Showcase Agentic Revenue Engagement Platform at Adobe Summit 2026, Demonstrating How Agentic AI Avatars and Content Intelligence Turn Static ABM Pages Into Real-Time Conversations

GlobeNewswire

5 hours ago

Azerion Group publishes its 2025 Annual Report

GlobeNewswire

6 hours ago

China International Consumer Products Expo 2026 Underway in Haikou with Over 3,400 Brands

GlobeNewswire

8 hours ago

Psyence BioMed Welcomes U.S. Executive Action to Advance Research into Ibogaine

GlobeNewswire

8 hours ago

iPower Adds Over $2.6 Million in Contracted, Non-Dilutive Income Through Sublease Agreement

GlobeNewswire

8 hours ago

Earth Day 2026: JMU faculty experts available to discuss environmental topics

GlobeNewswire

8 hours ago

Brain Technologies and SoftBank Launch Natural AI Phone in Japan

GlobeNewswire

8 hours ago

EverCommerce Announces Date of First Quarter 2026 Earnings Call

GlobeNewswire